Scarpini S, Nassiacos D, Meloni S, Recalcati F, Sali M, Belli C
II Divisione Cardiologica, Ospedale Maggiore Niguarda-Cà Granda, Milano.
G Ital Cardiol. 1990 Dec;20(12):1113-7.
In order to evaluate the effects of propafenone (an antiarrhythmic class 1 c agent) acutely administered intravenously on left ventricular function, 10 patients with acute myocardial infarction (AMI), affected by arrhythmias (greater than or equal to Lown class III), belonging to Killip class I and II, and with normal serum electrolyte levels, were studied 2-4 days after an acute episode. No patients had previously been treated with antiarrhythmic drugs, or, if treated, the agent was withdrawn since at least 4 half-lives. In no case were inotropic substances or other pharmacological treatments, capable affecting L.V. function administered. Intravenous nitroderivative (Venitrin) infusion was continued when indicated. Each patient was administered a propafenone bolus (1 mg pro Kg in 4 minutes). Two dimensional and Doppler echocardiography were performed under basal conditions i.e. before propafenone infusion, during the infusion and after 1, 2, 3 and 4 hours, deriving following parameters: L.V. end diastolic and end systolic dimensions and volumes, ejection fraction (area-length method), II motion abnormalities, and transmitral flow velocity profile (E/A ratio). Statistical data were obtained using two way analysis of variance.
In no case was the treatment interrupted, on the basis of our protocol criteria (reactions of hypersensitivity, proarrhythmic effects, acute hemodynamic deterioration that requires immediate positive inotropic and chronotropic agents administration, worsening of previous arrhythmic class). Heart rate and systemic arterial blood pressure did not change significatively during or after infusion.(ABSTRACT TRUNCATED AT 250 WORDS)
为了评估静脉内急性给予普罗帕酮(一种Ⅰc类抗心律失常药物)对左心室功能的影响,对10例急性心肌梗死(AMI)患者进行了研究,这些患者患有心律失常(大于或等于洛恩Ⅲ级),属于KillipⅠ级和Ⅱ级,血清电解质水平正常,在急性发作后2 - 4天进行研究。此前没有患者接受过抗心律失常药物治疗,或者如果接受过治疗,该药物已停用至少4个半衰期。在任何情况下都未给予能影响左心室功能的正性肌力物质或其他药物治疗。如有指征,静脉内硝基衍生物(硝酸甘油)输注持续进行。每位患者静脉推注普罗帕酮(4分钟内1mg/kg)。在基础条件下,即普罗帕酮输注前、输注期间以及输注后1、2、3和4小时进行二维和多普勒超声心动图检查,得出以下参数:左心室舒张末期和收缩末期内径及容积、射血分数(面积 - 长度法)、Ⅱ级运动异常以及二尖瓣血流速度剖面图(E/A比值)。使用双向方差分析获得统计数据。
根据我们的方案标准(过敏反应、促心律失常作用、需要立即给予正性肌力和变时性药物的急性血流动力学恶化、先前心律失常等级恶化),在任何情况下治疗均未中断。心率和体循环动脉血压在输注期间或之后均无显著变化。(摘要截断于250字)